Don’t Miss TipRanks’ Half-Year Sale
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
The latest announcement is out from AFT Pharmaceuticals Ltd. ( (AU:AFP) ).
AFT Pharmaceuticals reported a 6% increase in revenue to NZ$208,021,000 for the year ending March 31, 2025, but experienced a 23% decline in net profit to NZ$11,962,000. The company announced a dividend of $0.016 per equity security, reflecting its continued compliance with NZX and ASX listing rules.
More about AFT Pharmaceuticals Ltd.
AFT Pharmaceuticals Limited is a New Zealand-based company operating in the pharmaceutical industry. The company focuses on developing and distributing pharmaceutical products, catering to various market needs.
Average Trading Volume: 2,348
Technical Sentiment Signal: Strong Sell
Current Market Cap: A$255.3M
See more data about AFP stock on TipRanks’ Stock Analysis page.